DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
- Description:
Fluorescent A3 adenosine receptor antagonist
- Description:
Fluorescent β2 adrenoceptor antagonist
- Description:
Competitive fluorescent β2-adrenoceptor antagonist
- Description:
Fluorescent H1 histamine receptor antagonist
- Description:
Fluorescent H2 histamine receptor antagonist
- Description:
Fluorescent H3 histamine receptor antagonist
- Description:
Fluorescent M3 muscarinic receptor antagonist
- Description:
Fluorescent 5-HT2A receptor antagonist
Caffeine (HB2846)
Description:Non-selective, competitive adenosine receptor antagonist / PDE inhibitor